MSB 3.21% $1.13 mesoblast limited

Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA, page-72

  1. 12,543 Posts.
    lightbulb Created with Sketch. 3394
    Great news hey!
    The tonic we all need after a few disastrous years… something butterfly

    What do you think shorter or longer classification timeframes for this BLA review?
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.